Davis Jerel - Director, 10%+ Owner at Turnstone Biologics Corp.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
TSBX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Davis Jerel since 10/6/2023

Holdings reported by Davis Jerel for Turnstone Biologics Corp.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.73M Jul 25, 2023 By Versant Venture Capital V, L.P.
Common Stock 275K Jul 25, 2023 By Versant Vantage II, L.P.
Common Stock 207K Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Common Stock 90.9K Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Common Stock 82K Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Stock Option (Right to Buy) 12.8K Jun 3, 2024 Direct Common Stock
Series A Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P. Common Stock
Series A Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P. Common Stock
Series A Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP Common Stock
Series A Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P. Common Stock
Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P. Common Stock
Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P. Common Stock
Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP Common Stock
Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P. Common Stock
Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P. Common Stock
Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P. Common Stock
Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP Common Stock
Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P. Common Stock
Series C Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P. Common Stock
Series C Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P. Common Stock
Series C Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP Common Stock
Series C Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P. Common Stock
Series D Preferred Stock 0 Jul 25, 2023 By Versant Vantage II, L.P. Common Stock

Transactions reported by Davis Jerel for Turnstone Biologics Corp.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.